STOCK TITAN

electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and Neuroscience

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

electroCore, Inc. (NASDAQ: ECOR) announced that its cofounder and Chief Medical Officer, Dr. Peter Staats, will receive a Lifetime Achievement Award at the American Society of Pain and Neuroscience Annual Conference on July 24th, 2021. This award recognizes Dr. Staats' significant contributions to pain medicine, including over 450 published works. He has held leadership roles in various medical societies and is currently the President Elect of the World Institute of Pain. electroCore focuses on non-invasive vagus nerve stimulation therapies for migraine and cluster headache treatment.

Positive
  • Dr. Peter Staats receiving a Lifetime Achievement Award enhances the company's reputation.
  • Recognition of leadership in pain medicine can potentially attract partnerships or investments.
Negative
  • None.

ROCKAWAY, NJ, July 19, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its cofounder and Chief Medical Officer, Dr. Peter Staats, is to receive a Lifetime Achievement Award at the American Society of Pain and Neuroscience Annual Conference on July 24th, 2021.

Dr. Staats will be honored for his lifelong contribution to field of pain and neuromodulation, advancing the relief from pain through science, clinical education, and research. Dr. Staats has written or co-edited 13 books and over 450 articles, abstracts, monographs, and book chapters on pain medicine in publications that include the Journal of the American Medicine Association, Pain, Anesthesiology, Lancet Neurology and the Journal of Clinical Oncology.

Dr. Staats is the former President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society. He is currently President Elect of the World Institute of Pain and continues to serve as Chief Medical Officer for National Spine and Pain Centers, the largest pain practice in the United States, and electroCore, Inc.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.


FAQ

What award will Dr. Peter Staats receive?

Dr. Peter Staats will receive a Lifetime Achievement Award at the American Society of Pain and Neuroscience Annual Conference on July 24th, 2021.

What are electroCore's current treatment indications?

electroCore's current indications include preventive treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

Who is the Chief Medical Officer of electroCore?

The Chief Medical Officer of electroCore is Dr. Peter Staats.

What is electroCore focused on?

electroCore is dedicated to improving patient outcomes through non-invasive vagus nerve stimulation therapy.

What is the stock symbol for electroCore?

The stock symbol for electroCore is ECOR.

electroCore, Inc.

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Stock Data

71.05M
4.91M
25.02%
16.11%
0.67%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ROCKAWAY